お見積

サンプルお申込み

お問い合わせ

今すぐ購入

※ご注文方法：お問い合わせフォームまたはメールにてご連絡ください。
支払方法：「銀行振込」の場合， 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期：原則として、受注後2～4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8～10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

本報告書は、心室補助装置の世界市場、容量、生産量、収益、価格の概要を紹介します。2020~2024年の歴史的な市場収益/売上データ、2025年の予想、および2031年までのCAGRの予測を含む世界市場動向の分析。本レポートはメーカー、地域、製品の種類と端末業界の角度から世界と主要地域の市場現状と将来性を研究した、このレポートでは、世界と主要地域のトップメーカーを分析し、製品タイプとアプリケーション/端末業界別に心室補助装置市場を分類しています。
本レポートでは世界の心室補助装置市場の主な参加者として、企業概要、販売数量、収益、価格、粗利益率、ポートフォリオ、地理的位置、重要な発展を次のパラメータに基づいて紹介します。本研究に含まれる主な企業は：AbioMed、Abbott (Thoratec)、Medtronic (HeartWare)、Berlin Heart、Evaheart、CH Biomedical、ROCOR Medical、coretech medical、BiVACOR、CorWave

レポートは心室補助装置の主要生産者を調査し、主要地域や国の消費状況も提供します。心室補助装置の今後の市場の可能性のハイライト、およびこの市場をさまざまなセグメントおよびサブセグメントに予測するための主要な地域/国の焦点。アメリカとカナダ、中国、アジア、ヨーロッパ、中東、アフリカ、ラテンアメリカ、およびその他の国の国別データと市場価値分析。

2020年から2031年までのタイプ別および用途別、売上高、収益、価格別のセグメントデータを分析します。
タイプ別市場セグメント：
    LVADs
    RVADs
    BIVADs

用途別の市場セグメント：
    Bridge-to-transplant (BTT)
    Destination Therapy (DT)
    Other

本レポートの詳細内容
本レポートは、世界の心室補助装置市場の現状と将来展望を包括的に分析し、グローバルの主要地域における開発動向の綿密な調査を通じて、読者に包括的な市場分析を提示するものであります。市場の全体像を把握するために、プレイヤー、地域、製品タイプ、最終産業を網羅した多角的な分析を提供しています。さらに、世界市場のトッププレイヤーを特定し、プロファイルを作成するとともに、製品タイプや用途/最終産業に基づいて心室補助装置市場を細分化しています。この分類と応用により、市場の構造とダイナミクスをより深く理解することができ、情報に基づいた意思決定と戦略立案が可能になります。
一. 生産面では、2020年から2025年まで、そして2031年までの予測として、メーカー別、地域別（地域レベル、国レベル）の心室補助装置生産量、成長率、市場シェアを調査している。

二. 消費面では、心室補助装置の売上高を地域別（地域レベル・国レベル）、企業別、種類別、用途別に焦点を当てています。2020年から2025年まで、2031年までの予測。

三.主要メーカーの心室補助装置売上高、収益、市場シェア、業界ランキング、2020年から2025年までのデータに焦点を当てています。世界の心室補助装置市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づいて競争状況と市場ポジショニングの分析。

四.本心室補助装置のレポートでは関係者が市場の競争状況を包括的に理解し、事業戦略や市場戦略を的確に立てるのに役立つ洞察を提供することを目的としています。 売上高、成長動向、生産技術、用途、エンドユーザー産業の市場規模に関する詳細な評価と予測を提供し、意思決定者に強力なデータサポートを提供します。

章の概要
第1章：心室補助装置のレポート範囲、各市場セグメントの市場規模、将来の開発可能性などを含む、さまざまな市場セグメントのエグゼクティブサマリー（タイプ別およびアプリケーション別など）を紹介します。市場の現状と、短期から中期、および長期的な進化の可能性を高度に見ることができます。（2020～2031）
第2章： 心室補助装置の世界と主要生産者（地域／国）の生産／アウトプット。各生産者の生産量と今後6年間の発展可能性を定量的に分析しています。（2020～2031）
第3章：世界、地域、国レベルにおける心室補助装置の売上（消費）、収益。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界の各国の市場発展、将来の発展の見通し、市場空間を紹介します。（2020～2031）
第4章心室補助装置メーカーの競争状況、価格、売上高、収益、市場シェアと業界ランキング、最新の開発計画、合併、買収情報などの詳細分析。（2020～2025）
第5章：心室補助装置の各市場セグメントの売上高、収益、平均価格、および開発可能性をカバーした種類別のさまざまな市場セグメントの分析を提供し、読者がさまざまな市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。（2020～2031）
第6章：アプリケーション別の様々な市場セグメントの分析を提供し、各市場セグメントの売上高、収益、平均価格、発展の可能性をカバーし、読者が異なる下流市場でのブルーオーシャン市場を見つけるのに役立ちます。（2020～2031）
第7章：北米（米国・カナダ）：タイプ別、用途別、国別、セグメント別の売上高、収益。（2020～2031）
第8章：ヨーロッパ：タイプ別、用途別、国別、セグメント別の売上高と収益。（2020～2031）
第9章：中国：タイプ別、アプリケーション別、セグメント別の売上高、収益。（2020～2031）
第10章：アジア（中国を除く）：タイプ別、用途別、地域別、セグメント別の売上高、収益。（2020～2031）
第11章：中東、アフリカ、中南米：タイプ別、用途別、国別、セグメント別の売上高、収益。（2020～2031）
第12章：心室補助装置の主要メーカーの概要を提供し、製品の説明と仕様、心室補助装置の売上高、収益、価格、粗利益率、最近の発展など、市場の主要企業の基本的な状況を詳細に紹介します。（2020～2025）
第13章：産業チェーン、販売チャネル、主要原材料、販売代理店および顧客の分析。
第14章：心室補助装置の市場動態、市場の最新の動向、市場の推進要因と制約要因、業界内のメーカーが直面する課題とリスク、業界内の関連政策の分析を紹介します。
第15章：レポートの要点と結論。

Valued at US$ 1659 million in 2024, the global Ventricular Assist Device market is forecast to reach US$ 2651 million by 2030, at a CAGR of 8.1% during the forecast period.
Ventricular assist devices are mechanical pumps used to support cardiac circulation in patients who have weakened hearts.  A ventricular assist device (VAD) is an electromechanical device for assisting cardiac circulation, which is used either to partially or to completely replace the function of a failing heart. The function of VADs is different from that of artificial cardiac pacemakers; some are for short-term use, typically for patients recovering from myocardial infarction (heart attack) and for patients recovering from cardiac surgery; some are for long-term use (months to years to perpetuity), typically for patients suffering from advanced heart failure.
Market Driver: The growing prevalence of heart failure and cardiovascular diseases is a key driver for the Ventricular Assist Device (VAD) market. As the global aging population increases, so does the number of patients suffering from end-stage heart failure, leading to a higher demand for VADs as both a bridge-to-transplant and destination therapy. Additionally, advancements in VAD technology, such as smaller, more durable, and biocompatible devices with reduced complications, have improved patient outcomes and expanded the adoption of these devices. Government initiatives, increasing healthcare expenditures, and rising awareness of mechanical circulatory support systems further fuel market growth.
Market Challenge: Despite its growth, the VAD market faces significant challenges, primarily related to high costs and surgical risks. The implantation procedure for VADs is complex, requiring skilled surgeons and advanced medical infrastructure, which limits accessibility, especially in developing regions. Moreover, post-implantation complications, such as infections, thromboembolism, and device malfunction, remain concerns, necessitating continuous monitoring and long-term patient management. Regulatory hurdles and reimbursement limitations in certain countries also pose barriers to widespread adoption, slowing market expansion.
Report Includes
This report presents an overview of global market for Ventricular Assist Device, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Ventricular Assist Device, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Ventricular Assist Device, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Ventricular Assist Device sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Ventricular Assist Device market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Ventricular Assist Device sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including AbioMed, Abbott (Thoratec), Medtronic (HeartWare), Berlin Heart, Evaheart, CH Biomedical, ROCOR Medical, coretech medical, BiVACOR, CorWave, etc.

Market Segmentation
By Company
    AbioMed
    Abbott (Thoratec)
    Medtronic (HeartWare)
    Berlin Heart
    Evaheart
    CH Biomedical
    ROCOR Medical
    coretech medical
    BiVACOR
    CorWave

Segment by Type
    LVADs
    RVADs
    BIVADs

Segment by Application
    Bridge-to-transplant (BTT)
    Destination Therapy (DT)
    Other

Segment by region
    US & Canada
        U.S.
        Canada
    China
    Asia (excluding China)
        Japan
        South Korea
        China Taiwan
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        U.K.
        Italy
        Russia

Middle East, Africa, Latin America
        Brazil
        Mexico
        Turkey
        Israel
        GCC Countries

Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Ventricular Assist Device in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Ventricular Assist Device manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Ventricular Assist Device sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.

List of Tables
 Table 1. Global Ventricular Assist Device Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Major Manufacturers of LVADs
 Table 3. Major Manufacturers of RVADs
 Table 4. Major Manufacturers of BIVADs
 Table 5. Global Ventricular Assist Device Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 6. Global Ventricular Assist Device Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 7. Global Revenue by Region (2020-2025) & (US$ Million)
 Table 8. Global Revenue Market Share by Region (2020-2031)
 Table 9. Global Ventricular Assist Device Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Units)
 Table 10. Global Ventricular Assist Device Sales by Region (2020-2031) & (Units)
 Table 11. Global Sales Market Share by Region (2020-2031)
 Table 12. Global Ventricular Assist Device Sales by Manufacturers (2020-2025) & (Units)
 Table 13. Global Ventricular Assist Device Sales Share by Manufacturers (2020-2025)
 Table 14. Global Ventricular Assist Device Revenue by Manufacturers (2020-2025) & (US$ Million)
 Table 15. Global Ventricular Assist Device Revenue Market Share by Manufacturers (2020-2025)
 Table 16. Global Key Players of Ventricular Assist Device, Industry Ranking, 2023 VS 2024 VS 2024
 Table 17. Ventricular Assist Device Price by Manufacturers (2020-2025) & (K US$/Unit)
 Table 18. Global Ventricular Assist Device Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 19. Global Ventricular Assist Device by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ventricular Assist Device as of 2024)
 Table 20. Global Key Manufacturers of Ventricular Assist Device, Manufacturing Base Distribution and Headquarters
 Table 21. Global Key Manufacturers of Ventricular Assist Device, Product Offered and Application
 Table 22. Global Key Manufacturers of Ventricular Assist Device, Date of Enter into This Industry
 Table 23. Mergers & Acquisitions, Expansion Plans
 Table 24. Global Ventricular Assist Device Sales by Type (2020-2025) & (Units)
 Table 25. Global Ventricular Assist Device Sales by Type (2026-2031) & (Units)
 Table 26. Global Sales Share by Type (2020-2031)
 Table 27. Global Ventricular Assist Device Revenue by Type (2020-2025) & (US$ Million)
 Table 28. Global Ventricular Assist Device Revenue by Type (2026-2031) & (US$ Million)
 Table 29. Global Revenue Share by Type (2020-2031)
 Table 30. Ventricular Assist Device Price by Type (2020-2025) & (K US$/Unit)
 Table 31. Global Ventricular Assist Device Price Forecast by Type (2026-2031) & (K US$/Unit)
 Table 32. Global Ventricular Assist Device Sales by Application (2020-2025) & (Units)
 Table 33. Global Ventricular Assist Device Sales by Application (2026-2031) & (Units)
 Table 34. Global Sales Share by Application (2020-2031)
 Table 35. Global Ventricular Assist Device Revenue by Application (2020-2025) & (US$ Million)
 Table 36. Global Ventricular Assist Device Revenue by Application (2026-2031) & (US$ Million)
 Table 37. Global Revenue Share by Application (2020-2031)
 Table 38. Ventricular Assist Device Price by Application (2020-2025) & (K US$/Unit)
 Table 39. Global Ventricular Assist Device Price Forecast by Application (2026-2031) & (K US$/Unit)
 Table 40. US & Canada Sales by Type (2020-2031) & (Units)
 Table 41. US & Canada Revenue by Type (2020-2031) & (US$ Million)
 Table 42. US & Canada Sales by Application (2020-2031) & (Units)
 Table 43. US & Canada Revenue by Application (2020-2031) & (US$ Million)
 Table 44. US & Canada Ventricular Assist Device Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 45. US & Canada Revenue by Country (2020-2031) & (US$ Million)
 Table 46. US & Canada Sales by Country (2020-2031) & (Units)
 Table 47. Europe Sales by Type (2020-2031) & (Units)
 Table 48. Europe Revenue by Type (2020-2031) & (US$ Million)
 Table 49. Europe Sales by Application (2020-2031) & (Units)
 Table 50. Europe Revenue by Application (2020-2031) & (US$ Million)
 Table 51. Europe Ventricular Assist Device Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 52. Europe Sales by Country (2020-2031) & (Units)
 Table 53. Europe Revenue by Country (2020-2031) & (US$ Million)
 Table 54. China Sales by Type (2020-2031) & (Units)
 Table 55. China Revenue by Type (2020-2031) & (US$ Million)
 Table 56. China Sales by Application (2020-2031) & (Units)
 Table 57. China Revenue by Application (2020-2031) & (US$ Million)
 Table 58. Asia Sales by Type (2020-2031) & (Units)
 Table 59. Asia Revenue by Type (2020-2031) & (US$ Million)
 Table 60. Asia Sales by Application (2020-2031) & (Units)
 Table 61. Asia Revenue by Application (2020-2031) & (US$ Million)
 Table 62. Asia Ventricular Assist Device Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 63. Asia Revenue by Region (2020-2031) & (US$ Million)
 Table 64. Asia Sales by Region (2020-2031) & (Units)
 Table 65. Middle East, Africa and Latin America Sales by Type (2020-2031) & (Units)
 Table 66. Middle East, Africa and Latin America Revenue by Type (2020-2031) & (US$ Million)
 Table 67. Middle East, Africa and Latin America Sales by Application (2020-2031) & (Units)
 Table 68. Middle East, Africa and Latin America Revenue by Application (2020-2031) & (US$ Million)
 Table 69. Middle East, Africa and Latin America Ventricular Assist Device Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 70. Middle East, Africa and Latin America Revenue by Country (2020-2031) & (US$ Million)
 Table 71. Middle East, Africa and Latin America Sales by Country (2020-2031) & (Units)
 Table 72. AbioMed Company Information
 Table 73. AbioMed Description and Major Businesses
 Table 74. AbioMed Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
 Table 75. AbioMed Product Model Numbers, Pictures, Descriptions and Specifications
 Table 76. AbioMed Recent Developments
 Table 77. Abbott (Thoratec) Company Information
 Table 78. Abbott (Thoratec) Description and Major Businesses
 Table 79. Abbott (Thoratec) Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
 Table 80. Abbott (Thoratec) Product Model Numbers, Pictures, Descriptions and Specifications
 Table 81. Abbott (Thoratec) Recent Developments
 Table 82. Medtronic (HeartWare) Company Information
 Table 83. Medtronic (HeartWare) Description and Major Businesses
 Table 84. Medtronic (HeartWare) Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
 Table 85. Medtronic (HeartWare) Product Model Numbers, Pictures, Descriptions and Specifications
 Table 86. Medtronic (HeartWare) Recent Developments
 Table 87. Berlin Heart Company Information
 Table 88. Berlin Heart Description and Major Businesses
 Table 89. Berlin Heart Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
 Table 90. Berlin Heart Product Model Numbers, Pictures, Descriptions and Specifications
 Table 91. Berlin Heart Recent Developments
 Table 92. Evaheart Company Information
 Table 93. Evaheart Description and Major Businesses
 Table 94. Evaheart Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
 Table 95. Evaheart Product Model Numbers, Pictures, Descriptions and Specifications
 Table 96. Evaheart Recent Developments
 Table 97. CH Biomedical Company Information
 Table 98. CH Biomedical Description and Major Businesses
 Table 99. CH Biomedical Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
 Table 100. CH Biomedical Product Model Numbers, Pictures, Descriptions and Specifications
 Table 101. CH Biomedical Recent Developments
 Table 102. ROCOR Medical Company Information
 Table 103. ROCOR Medical Description and Major Businesses
 Table 104. ROCOR Medical Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
 Table 105. ROCOR Medical Product Model Numbers, Pictures, Descriptions and Specifications
 Table 106. ROCOR Medical Recent Developments
 Table 107. coretech medical Company Information
 Table 108. coretech medical Description and Major Businesses
 Table 109. coretech medical Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
 Table 110. coretech medical Product Model Numbers, Pictures, Descriptions and Specifications
 Table 111. coretech medical Recent Developments
 Table 112. BiVACOR Company Information
 Table 113. BiVACOR Description and Major Businesses
 Table 114. BiVACOR Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
 Table 115. BiVACOR Product Model Numbers, Pictures, Descriptions and Specifications
 Table 116. BiVACOR Recent Developments
 Table 117. CorWave Company Information
 Table 118. CorWave Description and Major Businesses
 Table 119. CorWave Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
 Table 120. CorWave Product Model Numbers, Pictures, Descriptions and Specifications
 Table 121. CorWave Recent Developments
 Table 122. Key Raw Materials Lists
 Table 123. Raw Materials Key Suppliers Lists
 Table 124. Distributors List
 Table 125. Customers List
 Table 126. Market Trends
 Table 127. Market Drivers
 Table 128. Market Challenges
 Table 129. Market Restraints
 Table 130. Research Programs/Design for This Report
 Table 131. Key Data Information from Secondary Sources
 Table 132. Key Data Information from Primary Sources


List of Figures
 Figure 1. Ventricular Assist Device Product Picture
 Figure 2. Global Ventricular Assist Device Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Global Ventricular Assist Device Market Share by Type: 2024 & 2031
 Figure 4. LVADs Product Picture
 Figure 5. RVADs Product Picture
 Figure 6. BIVADs Product Picture
 Figure 7. Global Ventricular Assist Device Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 8. Global Ventricular Assist Device Market Share by Application: 2024 & 2031
 Figure 9. Bridge-to-transplant (BTT)
 Figure 10. Destination Therapy (DT)
 Figure 11. Other
 Figure 12. Ventricular Assist Device Report Years Considered
 Figure 13. Global Ventricular Assist Device Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Ventricular Assist Device Revenue (2020-2031) & (US$ Million)
 Figure 15. Global Ventricular Assist Device Revenue by Region (2020-2031) (US$ Million)
 Figure 16. Global Ventricular Assist Device Revenue Market Share by Region in Percentage: 2024 Versus 2031
 Figure 17. Global Ventricular Assist Device Revenue Market Share by Region (2020-2031)
 Figure 18. Global Ventricular Assist Device Sales (2020-2031) & (Units)
 Figure 19. Global Ventricular Assist Device Sales (CAGR) by Region: 2020 VS 2024 VS 2031 (Units)
 Figure 20. Global Ventricular Assist Device Sales Market Share by Region (2020-2031)
 Figure 21. US & Canada Ventricular Assist Device Sales YoY (2020-2031) & (Units)
 Figure 22. US & Canada Ventricular Assist Device Revenue YoY (2020-2031) & (US$ Million)
 Figure 23. Europe Ventricular Assist Device Sales YoY (2020-2031) & (Units)
 Figure 24. Europe Ventricular Assist Device Revenue YoY (2020-2031) & (US$ Million)
 Figure 25. China Ventricular Assist Device Sales YoY (2020-2031) & (Units)
 Figure 26. China Ventricular Assist Device Revenue YoY (2020-2031) & (US$ Million)
 Figure 27. Asia (excluding China) Ventricular Assist Device Sales YoY (2020-2031) & (Units)
 Figure 28. Asia (excluding China) Ventricular Assist Device Revenue YoY (2020-2031) & (US$ Million)
 Figure 29. Middle East, Africa and Latin America Ventricular Assist Device Sales YoY (2020-2031) & (Units)
 Figure 30. Middle East, Africa and Latin America Ventricular Assist Device Revenue YoY (2020-2031) & (US$ Million)
 Figure 31. Global Ventricular Assist Device Sales Share by Manufacturers (2024)
 Figure 32. The Ventricular Assist Device Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2024
 Figure 33. Global Ventricular Assist Device Revenue Share by Manufacturers (2024)
 Figure 34. The Top 5 and 10 Largest Manufacturers of Ventricular Assist Device in the World: Market Share by Ventricular Assist Device Revenue in 2024
 Figure 35. Global Ventricular Assist Device Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 36. Global Ventricular Assist Device Sales Market Share by Type (2020-2031)
 Figure 37. Global Ventricular Assist Device Revenue Market Share by Type (2020-2031)
 Figure 38. Global Ventricular Assist Device Sales Market Share by Application (2020-2031)
 Figure 39. Global Ventricular Assist Device Revenue Market Share by Application (2020-2031)
 Figure 40. US & Canada Ventricular Assist Device Sales Market Share by Type (2020-2031)
 Figure 41. US & Canada Ventricular Assist Device Revenue Market Share by Type (2020-2031)
 Figure 42. US & Canada Ventricular Assist Device Sales Market Share by Application (2020-2031)
 Figure 43. US & Canada Ventricular Assist Device Revenue Market Share by Application (2020-2031)
 Figure 44. US & Canada Ventricular Assist Device Revenue Share by Country (2020-2031)
 Figure 45. US & Canada Ventricular Assist Device Sales Share by Country (2020-2031)
 Figure 46. US Ventricular Assist Device Revenue (2020-2031) & (US$ Million)
 Figure 47. Canada Ventricular Assist Device Revenue (2020-2031) & (US$ Million)
 Figure 48. Europe Ventricular Assist Device Sales Market Share by Type (2020-2031)
 Figure 49. Europe Ventricular Assist Device Revenue Market Share by Type (2020-2031)
 Figure 50. Europe Ventricular Assist Device Sales Market Share by Application (2020-2031)
 Figure 51. Europe Ventricular Assist Device Revenue Market Share by Application (2020-2031)
 Figure 52. Europe Ventricular Assist Device Sales Share by Country (2020-2031)
 Figure 53. Europe Ventricular Assist Device Revenue Share by Country (2020-2031)
 Figure 54. Germany Ventricular Assist Device Revenue (2020-2031) & (US$ Million)
 Figure 55. France Ventricular Assist Device Revenue (2020-2031) & (US$ Million)
 Figure 56. U.K. Ventricular Assist Device Revenue (2020-2031) & (US$ Million)
 Figure 57. Italy Ventricular Assist Device Revenue (2020-2031) & (US$ Million)
 Figure 58. Russia Ventricular Assist Device Revenue (2020-2031) & (US$ Million)
 Figure 59. China Ventricular Assist Device Sales Market Share by Type (2020-2031)
 Figure 60. China Ventricular Assist Device Revenue Market Share by Type (2020-2031)
 Figure 61. China Ventricular Assist Device Sales Market Share by Application (2020-2031)
 Figure 62. China Ventricular Assist Device Revenue Market Share by Application (2020-2031)
 Figure 63. Asia Ventricular Assist Device Sales Market Share by Type (2020-2031)
 Figure 64. Asia Ventricular Assist Device Revenue Market Share by Type (2020-2031)
 Figure 65. Asia Ventricular Assist Device Sales Market Share by Application (2020-2031)
 Figure 66. Asia Ventricular Assist Device Revenue Market Share by Application (2020-2031)
 Figure 67. Asia Ventricular Assist Device Revenue Share by Region (2020-2031)
 Figure 68. Asia Ventricular Assist Device Sales Share by Region (2020-2031)
 Figure 69. Japan Ventricular Assist Device Revenue (2020-2031) & (US$ Million)
 Figure 70. South Korea Ventricular Assist Device Revenue (2020-2031) & (US$ Million)
 Figure 71. China Taiwan Ventricular Assist Device Revenue (2020-2031) & (US$ Million)
 Figure 72. Southeast Asia Ventricular Assist Device Revenue (2020-2031) & (US$ Million)
 Figure 73. India Ventricular Assist Device Revenue (2020-2031) & (US$ Million)
 Figure 74. Australia Ventricular Assist Device Revenue (2020-2031) & (US$ Million)
 Figure 75. Middle East, Africa and Latin America Ventricular Assist Device Sales Market Share by Type (2020-2031)
 Figure 76. Middle East, Africa and Latin America Ventricular Assist Device Revenue Market Share by Type (2020-2031)
 Figure 77. Middle East, Africa and Latin America Ventricular Assist Device Sales Market Share by Application (2020-2031)
 Figure 78. Middle East, Africa and Latin America Ventricular Assist Device Revenue Market Share by Application (2020-2031)
 Figure 79. Middle East, Africa and Latin America Ventricular Assist Device Revenue Share by Country (2020-2031)
 Figure 80. Middle East, Africa and Latin America Ventricular Assist Device Sales Share by Country (2020-2031)
 Figure 81. Brazil Ventricular Assist Device Revenue (2020-2031) & (US$ Million)
 Figure 82. Mexico Ventricular Assist Device Revenue (2020-2031) & (US$ Million)
 Figure 83. Turkey Ventricular Assist Device Revenue (2020-2031) & (US$ Million)
 Figure 84. Israel Ventricular Assist Device Revenue (2020-2031) & (US$ Million)
 Figure 85. GCC Countries Ventricular Assist Device Revenue (2020-2031) & (US$ Million)
 Figure 86. Value Chain
 Figure 87. Ventricular Assist Device Production Process
 Figure 88. Channels of Distribution (Direct Vs Distribution)
 Figure 89. Bottom-up and Top-down Approaches for This Report
 Figure 90. Data Triangulation
 Figure 91. Key Executives Interviewed